Berman Capital Advisors, LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 208 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.

Quarter-by-quarter ownership
Berman Capital Advisors, LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$1,00014
+180.0%
0.00%
Q2 2021$050.0%0.00%
Q1 2021$0
-100.0%
5
-75.0%
0.00%
Q1 2020$1,000
-80.0%
20
-60.8%
0.00%
-100.0%
Q4 2019$5,0000.0%510.0%0.00%
-50.0%
Q3 2019$5,000
+150.0%
51
+168.4%
0.00%
+100.0%
Q2 2019$2,0000.0%19
-13.6%
0.00%0.0%
Q1 2019$2,00022
+266.7%
0.00%
Q4 2018$060.00%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Knott David M Jr 115,000$8,4593.32%
VILLERE ST DENIS J & CO LLC 480,807$35,368,1622.57%
Chicago Capital, LLC 449,508$33,065,8221.64%
RICE HALL JAMES & ASSOCIATES, LLC 288,345$21,210,6811.20%
Smith, Graham & Co., Investment Advisors, LP 65,163$4,793,3900.58%
Stephens Investment Management Group LLC 455,089$33,476,3470.56%
CARDINAL CAPITAL MANAGEMENT LLC /CT 201,993$14,858,6050.53%
WOODSTOCK CORP 52,604$3,869,5500.49%
Court Place Advisors, LLC 15,533$1,142,6070.41%
Jackson Creek Investment Advisors LLC 12,726$9360.39%
View complete list of LIGAND PHARMACEUTICALS INC shareholders